Share & Earn

Althealth

Topamax and Lyme disease – a phase IV clinical study of FDA data

0 2 years ago

The phase IV clinical study analyzes which people take Topamax and have Lyme disease. It is created by eHealthMe based on reports of 46,725 people who have side effects when taking Topamax from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added.

What is Topamax?

Topamax has active ingredients of topiramate. It is often used in migraine. eHealthMe is studying from 52,407 Topamax users for its effectiveness, alternative drugs and more.

Time on Topamax when people have Lyme disease *:

  • < 1 month: 0.0 %
  • 1 – 6 months: 66.67 %
  • 6 – 12 months: 33.33 %
  • 1 – 2 years: 0.0 %
  • 2 – 5 years: 0.0 %
  • 5 – 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Lyme disease when taking Topamax *:

  • female: 90.48 %
  • male: 9.52 %

Age of people who have Lyme disease when taking Topamax *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 14.29 %
  • 20-29: 0.0 %
  • 30-39: 42.86 %
  • 40-49: 42.86 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common conditions people have *:

  1. Narcolepsy (brain’s inability to regulate sleep-wake cycles normally): 9 people, 42.86%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 19.05%
  3. Stress And Anxiety: 3 people, 14.29%
  4. Pain: 3 people, 14.29%
  5. Irritable Bowel Syndrome: 3 people, 14.29%
  6. Panic Disorder: 2 people, 9.52%
  7. Seasonal Allergy (allergic condition due to certain season): 2 people, 9.52%
  8. Sleep Disorder: 2 people, 9.52%
  9. Depression: 2 people, 9.52%
  10. Insomnia (sleeplessness): 2 people, 9.52%

READ FULL STUDY

Leave a Comment

Your email address will not be published. Required fields are marked *